⚕️ Educational information only — not medical advice. Read the full disclaimer

Rheumatoid Arthritis: An Evidence-Graded Deep Dive

Rheumatoid arthritis (RA) is not "wear and tear." It is a chronic autoimmune disease: the immune system attacks the synovium, the thin lining of the joints. Left untreated, that inflammation can erode cartilage and bone within months, and it affects the heart, lungs, and blood vessels too. This page covers what is known and what is still being worked out. It looks at how RA autoimmunity seems to start (often years before the first swollen joint), the evidence on gums, lungs, gut, smoking, weight, hormones and viruses, why early treatment by a rheumatologist matters so much, and which lifestyle measures have real evidence behind them.

Important: This page is general educational information, not medical advice. RA is a serious disease that needs care from a physician, ideally a rheumatologist. The lifestyle measures described here are meant to support medical treatment, not replace it. Never stop, reduce, or delay a prescribed medication without speaking to the prescribing physician.

Key takeaways

  • RA is an autoimmune disease affecting roughly 0.5–1% of adults, and women about two to three times as often as men. Strong
  • Treat it early. Starting disease-modifying drugs (DMARDs) in the first months after symptoms begin is linked to less joint damage and better long-term outcomes. This is the single most important thing on this page. Strong
  • Anti-CCP antibodies are highly specific for RA and can be detected years before joints swell, so the disease process starts well before the symptoms. Strong
  • Smoking is the best-established environmental risk factor, especially for anti-CCP-positive RA in people carrying "shared epitope" genes. Strong
  • The mucosal origins hypothesis proposes that RA autoimmunity may begin in the gums (P. gingivalis), the lungs, or the gut (Prevotella copri). It is plausible but not yet proven. Emerging
  • Exercise, quitting smoking, and a Mediterranean-style diet are sensible additions to medical care. Omega-3 has at most small benefits. Fasting followed by a vegetarian diet helped in a 1991 trial, but a 2022 trial found no advantage over a healthy guideline-based diet. Strong Emerging Contested

What RA is: autoimmunity basics Strong

In RA the immune system loses tolerance to some of the body's own proteins. Immune cells (T cells, B cells, and macrophages) move into the synovium. The synovium thickens into an inflamed, invasive tissue called pannus, and it releases inflammatory messengers such as TNF-α and IL-6. Over time this tissue erodes cartilage and the bone next to it. Many modern RA medicines (TNF inhibitors, IL-6 receptor blockers, JAK inhibitors, B-cell and T-cell therapies) work by blocking one of these steps directly.12

Mechanism: genes plus environment

The strongest genetic risk comes from certain HLA-DRB1 alleles that share a short amino-acid sequence called the "shared epitope." These molecules present peptides to T cells. They seem to be especially good at presenting citrullinated proteins (proteins in which the amino acid arginine has been chemically converted to citrulline). The body makes citrullinated proteins during inflammation, for example in smokers' lungs or in inflamed gums. In genetically susceptible people this can lead to an immune response against them. This gene–environment model is among the best-supported explanations for how RA starts.8

RA is a systemic disease. It raises the risk of cardiovascular disease by about 50% compared with the general population (pooled relative risk 1.48; about 1.7 for heart attack).30 It can also involve the lungs (interstitial lung disease), eyes, skin (rheumatoid nodules), and blood vessels. This is part of why controlling inflammation matters beyond the joints.22

Who gets RA Strong

~18MPeople living with RA worldwide (WHO, 2019 estimate)
~70%Of people with RA are women
0.5–1%Typical adult prevalence in many North American and European studies (lower in global estimates)

The World Health Organization estimates that about 18 million people were living with RA in 2019. Around 70% were women, and more than half were older than 55.4 The Global Burden of Disease study gives a similar figure, about 17.6 million in 2020, an age-standardised prevalence of roughly 0.2% of the whole population, with women affected about 2.5 times as often as men.29 RA can start at any age, but onset is most common between the 30s and 60s. Risk is higher in people with a family history of RA.35

Anti-CCP and rheumatoid factor Strong

Two blood tests are central to diagnosing RA. They are also important for understanding how it develops. More detail on interpreting these and related markers is on our rheumatoid arthritis biomarkers guide.

The two key RA autoantibodies
TestWhat it detectsStrengthsLimitations
Anti-CCP (ACPA)Antibodies against citrullinated proteinsVery specific for RA (around 95%). Can appear years before symptoms. Linked to more erosive disease.Negative in roughly a third of people with RA
Rheumatoid factor (RF)Antibodies against the Fc portion of IgGLong-established. High levels support the diagnosis.Less specific. Can be positive in other autoimmune diseases, chronic infections, and some healthy older adults.

Key finding: the disease starts before the symptoms

Studies of stored blood samples from blood donors and population cohorts found that anti-CCP and RF were often present years before RA symptoms began. In a Dutch blood-donor study, about half of patients tested positive before their first symptoms, a median of 4.5 years earlier. In a Swedish cohort, antibodies became more common as onset approached: anti-CCP was found in 25% of samples taken more than 1.5 years before symptoms and in 52% of those taken closer to onset.1213 Researchers call this silent period "pre-RA" (or pre-clinical RA). It is the main reason scientists suspect RA begins somewhere other than the joints.

Seronegative RA (negative for both RF and anti-CCP) is real and can be just as active. A negative blood test does not rule out RA, and a positive RF alone does not confirm it. A doctor interprets these results together with the joint examination, inflammation markers (CRP, ESR), and sometimes imaging.

The mucosal origins hypothesis: gums, lungs, gut Emerging

If autoantibodies appear years before joint symptoms, where are they first produced? A leading hypothesis is that RA autoimmunity often begins at a mucosal surface (the lining of the mouth, airways, or intestine), where the immune system is constantly exposed to microbes and irritants. Local inflammation there may generate citrullinated proteins and break tolerance. Later, the immune response "migrates" to the joints.11 We cover this at length because the mechanism is plausible and well studied. It is still a hypothesis, though. No single mucosal site has been shown to cause RA, and the proposed sites may differ between people. For the broader holistic framing, see root causes of arthritis.

Proposed mucosal sites where RA autoimmunity may begin
SiteProposed triggerProposed mechanismEvidence
GumsPorphyromonas gingivalis, periodontitisBacterial enzyme (PPAD) citrullinates proteins; chronic gum inflammationEmerging
LungsSmoking, silica, other inhaled irritantsAirway inflammation increases citrullination in lung tissue; anti-CCP may be produced locallyStrong (smoking) / Emerging (lung origin)
GutPrevotella copri expansion, dysbiosisMicrobiome shifts may skew mucosal immunity toward a pro-inflammatory (Th17) stateEmerging

Gums and P. gingivalis

Periodontitis is more common in people with RA, and the association runs in both directions. P. gingivalis, a key periodontal pathogen, is unusual because it produces its own peptidylarginine deiminase (PPAD). This enzyme can citrullinate both bacterial and human proteins, which offers a direct molecular link to the anti-CCP response.1011 Other gum bacteria, such as Aggregatibacter actinomycetemcomitans, have also been implicated. Association is not causation, however. Periodontal disease shares risk factors with RA (smoking, for example), and trials of gum treatment are small.

The lungs

Smoking is the clearest environmental RA risk (see below), and the lung is a natural place to look for the start of the disease. Citrullinated proteins have been found in the airways of smokers. Some anti-CCP-positive people without joint symptoms already show airway abnormalities, which suggests that in at least some people, autoimmunity may be triggered in the lung.118

The gut and Prevotella copri

A widely cited 2013 study found that Prevotella copri was overrepresented in the gut microbiome of people with new-onset, untreated RA. In mice, colonization with P. copri made colitis worse.9 Later work has reported immune responses to Prevotella proteins in some RA patients. The findings are intriguing, but microbiome studies are small and vary by population. They also cannot yet show whether the microbial changes are a cause or a consequence. No probiotic or "microbiome protocol" has been shown to prevent or treat RA.

Smoking, obesity, sex hormones & EBV

RA risk factors at a glance
FactorWhat the evidence showsModifiable?Evidence
Cigarette smokingAbout 1.9× the risk in men and 1.3× in women who have ever smoked; about 3× for RF-positive RA in men; higher with 20+ pack-years.15 Risk falls slowly after quitting but stays modestly raised for decades.31YesStrong
HLA-DRB1 shared epitopeMain genetic risk. Interacts with smoking to raise risk sharply for anti-CCP-positive RA.NoStrong
ObesityModestly higher RA risk (about 1.3× for obesity)16 and lower odds of reaching remission on treatment32YesStrong (association)
Female sex / hormones2–3× higher risk in women. Disease activity often improves in pregnancy and may flare after delivery.NoStrong (sex) / Emerging (hormonal mechanisms)
PeriodontitisMore common in RA; plausible citrullination mechanismYesEmerging
Epstein-Barr virus (EBV)Altered immune responses to EBV reported in RA; causal role unprovenNo (largely)Contested

Smoking Strong

A meta-analysis of 16 observational studies found that men who had ever smoked had about 1.9 times the risk of developing RA (about 3 times for rheumatoid-factor-positive RA) and women about 1.3 times, with higher risk after 20 or more pack-years.15 The effect is concentrated in anti-CCP-positive RA. In people carrying two copies of shared-epitope genes, a history of smoking was linked to about 21 times the risk of anti-CCP-positive RA compared with non-smokers without these genes.8 Smoking is also linked to more severe disease and a poorer response to some medications. It is the most important modifiable risk factor we know of. More on environmental exposures is on lifestyle & toxins.

Obesity Strong (association)

Higher body-mass index is associated with a modestly increased risk of developing RA: in a meta-analysis of 11 studies, obesity carried about 1.3 times the risk of normal weight.16 Once someone has RA, obesity is associated with higher disease activity and lower remission rates (pooled odds of remission about 40% lower).32 It can also make joint swelling harder to assess and inflammation markers harder to interpret. Fat tissue releases inflammatory signals (adipokines), which may partly explain the link. The metabolic side of this is covered in root causes.

Sex hormones Emerging (mechanisms)

RA's strong female predominance is well established. Many women experience milder disease during pregnancy and a flare in the months after delivery.17 Onset also clusters around the perimenopausal years. These patterns point to a role for estrogen, progesterone, and pregnancy-related immune changes. However, studies of oral contraceptives and hormone therapy have produced inconsistent results, and the exact mechanisms are not settled. Hormone-related decisions belong with your physician.

Epstein-Barr virus Contested

Almost everyone carries EBV by adulthood. Studies have reported higher EBV viral loads and altered T-cell responses to EBV in people with RA, as well as possible molecular mimicry between EBV proteins and self-proteins.18 Strong evidence links EBV to multiple sclerosis. For RA, the evidence remains mixed, and it is unclear whether these findings are a cause or a result of immune dysregulation.

The window of opportunity: why early treatment matters Strong

If you have joints that stay swollen for more than a few weeks, see a doctor promptly and ask whether you should be referred to a rheumatologist. Evidence consistently shows that the first months of RA are a critical period, and that early treatment with disease-modifying drugs changes the long-term course of the disease. No diet, supplement, or lifestyle program has been shown to do this. Waiting to "try natural approaches first" can cost permanent joint damage.

Bone erosions can show up on imaging within the first months of RA. A meta-analysis of early-arthritis studies found that patients who started DMARDs earlier had significantly less radiographic progression over the long term than those whose treatment was delayed.19 This has become known as the "window of opportunity": a period early in the disease, often described as the first three to six months after symptoms begin, when treatment appears most effective at preventing damage and reaching remission.

Current EULAR and ACR guidelines therefore recommend:67

  • Start a DMARD as soon as RA is diagnosed. Methotrexate is the usual first choice unless there is a reason not to use it.
  • Treat to target: aim for remission (or at least low disease activity), check disease activity regularly, and adjust therapy if the target is not reached, typically within three to six months.
  • Use glucocorticoids (steroids) only short term as a bridge while DMARDs take effect, and taper them as quickly as is clinically possible.
  • Escalate to biologic or targeted synthetic DMARDs (such as TNF inhibitors, IL-6 blockers, abatacept, rituximab, or JAK inhibitors) when needed. The 2025 EULAR update advises adding a biologic first and considering JAK inhibitors only after weighing cardiovascular, cancer and blood-clot risks.

With this approach, remission or low disease activity is a realistic goal for many people with RA today. Our medications page discusses certain drug side effects and nutrient interactions. Talk through any concerns about medications with your rheumatologist. Do not stop them on your own.

Symptoms Strong

Typical joint features

  • Swollen, tender, warm joints, often the small joints of the hands (knuckles and middle finger joints), wrists, and feet
  • Usually symmetrical (both sides of the body)
  • Morning stiffness lasting more than 30 minutes, often an hour or more
  • Pain when squeezing across the knuckles or the balls of the feet
  • Symptoms that persist for weeks rather than days

Whole-body features

  • Fatigue, sometimes profound
  • Low-grade fever, reduced appetite, weight loss
  • Rheumatoid nodules (firm lumps under the skin, often at the elbows)
  • Dry eyes and mouth
  • Less commonly: shortness of breath, chest pain, or eye inflammation

RA usually starts gradually, but it can begin suddenly. Unlike osteoarthritis, which tends to worsen with use and ease with rest, RA stiffness is typically worst after rest and eases with movement.25

How RA is diagnosed (2010 ACR/EULAR criteria) Strong

Full guide: Rheumatoid arthritis vs osteoarthritis — how to tell them apart: joint patterns, morning stiffness and blood tests.

There is no single test for RA. A rheumatologist combines the history, joint examination, blood tests, and sometimes ultrasound or X-rays. In 2010, the American College of Rheumatology and EULAR published classification criteria designed to identify RA earlier than older criteria allowed.14 They apply to people with at least one clearly swollen joint that is not better explained by another disease. A score of 6 or more out of 10 classifies the case as definite RA.

2010 ACR/EULAR classification criteria for RA (overview)
DomainCategoriesPoints
A. Joint involvement1 large joint / 2–10 large joints / 1–3 small joints / 4–10 small joints / more than 10 joints (at least 1 small)0 / 1 / 2 / 3 / 5
B. Serology (RF and anti-CCP)Both negative / low-positive / high-positive (more than 3× upper limit of normal)0 / 2 / 3
C. Acute-phase reactants (CRP, ESR)Both normal / either abnormal0 / 1
D. Symptom durationLess than 6 weeks / 6 weeks or more0 / 1
Note: These are classification criteria, built for research and to support early diagnosis. They are not a self-test. A person can have RA and score below 6, especially very early on. Many other conditions can also cause swollen joints, including psoriatic arthritis, lupus, gout, viral arthritis, and reactive arthritis. Only a clinician can sort these out.

Evidence-graded complementary measures

These measures can complement medical treatment. None replaces DMARDs. EULAR's lifestyle recommendations for people with rheumatic and musculoskeletal diseases emphasize exercise, a healthy weight, not smoking, and a healthy diet, partly because they reduce the cardiovascular risk that comes with RA.2122

Complementary measures for RA: what the evidence shows
MeasureWhat studies showEvidence
Smoking cessationLowers cardiovascular risk, and in a large cohort of women RA risk fell with longer time since quitting.31 Smokers tend to have more active disease and respond less well to some drugs.Strong
Exercise (aerobic + strength)Improves function, fitness, fatigue, and cardiovascular health without worsening disease activity. Recommended by EULAR.Strong
Healthy weightObesity is linked to higher disease activity and lower remission rates.32 Weight loss trials in RA are limited.Emerging
Mediterranean-style dietSmall randomized trials report modest improvements in pain and disease activity. Clear cardiovascular benefits.Emerging
Omega-3 fish oil (EPA/DHA)Some trials report less NSAID use or morning stiffness; a 2024 meta-analysis of 23 trials found only small, uncertain effects.Emerging
Periodontal careA meta-analysis of 9 small studies found non-surgical gum treatment lowered DAS28 by about 0.6 in people with RA and periodontitis.33 Good dental care is worthwhile regardless.Emerging
Fasting followed by vegetarian dietA 1991 trial found benefits that lasted a year on a vegetarian diet; after fasting alone, most people relapse when food is reintroduced. A 2022 trial found no advantage over a healthy guideline diet.2734Contested

Mediterranean diet Emerging

In a Swedish trial, people with RA who switched to a Cretan-style Mediterranean diet for 12 weeks had modest reductions in disease activity and improved physical function compared with controls.24 Subsequent trials have been small. A Cochrane review of dietary interventions for RA judged the overall evidence uncertain.23 Because the Mediterranean pattern also lowers cardiovascular risk, which is elevated in RA, it is a reasonable, low-risk choice. See our anti-inflammatory diet plan and foods to avoid for practical detail.

Omega-3 fatty acids Emerging

Fish oil supplements rich in EPA and DHA have been tested in RA for decades. A randomized trial in early RA found that adding high-dose fish oil to methotrexate-based treatment was associated with higher remission rates and less treatment failure than a low-dose control.25 Pooled across 23 placebo-controlled trials, though, effects on pain and joint counts were small and uncertain.28 In the large VITAL prevention trial, vitamin D (with or without omega-3) was associated with about 22% fewer new autoimmune diseases; omega-3 alone did not reach statistical significance.26 A 2024 follow-up weakened the vitamin D result: once later-confirmed cases were added, the effect during the trial was no longer significant (HR 0.85, 95% CI 0.70–1.04), and it had faded two years after participants stopped taking it (HR 0.98). Omega-3, by contrast, showed a small significant reduction at seven years (HR 0.83).35 The trial was not specific to RA, so treat this as Emerging evidence. High doses can interact with blood thinners, so discuss supplements with your doctor first.

Exercise Strong

EULAR recommends that people with inflammatory arthritis do regular aerobic exercise, strength training, flexibility work, and balance training, adapted to their condition. Exercise is safe in RA and does not accelerate joint damage. It improves function, fatigue, mood, and cardiovascular health. A 2025 update of these recommendations keeps physical-activity promotion as part of standard care and adds advice on cutting sedentary time.20 A physiotherapist can help tailor a program during flares.

Smoking cessation Strong

Quitting is the single most valuable lifestyle change for someone with or at risk of RA. It lowers cardiovascular and lung risk and is associated with better treatment responses. Ask your doctor about cessation support, since medication and counseling improve the chances of quitting.21

Periodontal care Emerging

Given the gum–RA link, regular dental check-ups, cleaning, and treatment of periodontitis make sense. Small studies suggest non-surgical periodontal treatment may modestly improve RA disease activity: a meta-analysis of 9 studies found DAS28 about 0.6 lower, along with lower CRP, but larger trials are needed.1133 Good oral hygiene is worthwhile regardless, and RA in the hands can make brushing and flossing harder. Electric toothbrushes and floss holders can help.

Fasting Contested

In a well-known 1991 controlled trial, patients who underwent a 7–10 day modified fast followed by a year of individually adjusted vegetarian diet improved significantly compared with controls, and the benefits were still present after one year. The same authors note that most patients relapse when food is reintroduced after fasting alone, and the trial was small (53 patients) and only single-blind.27 A 2022 randomized trial in 53 patients found that a 7-day fast followed by a plant-based diet was no better than a guideline-based healthy diet for physical function at 12 weeks; both groups improved.34 A Cochrane review judged the effects of dietary interventions uncertain because the trials are small with moderate to high risk of bias, and noted more drop-outs and weight loss in the diet groups.23 Prolonged fasting is not appropriate for everyone, especially people taking steroids, diabetes medication, or methotrexate, or anyone underweight. Do not attempt it without medical supervision.

Dietary & supplement note: Statements here about nutrients and dietary supplements have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease.

Red flags: when to seek care urgently

Seek urgent medical attention (emergency department or same-day care) if you have:
  • A single hot, very painful, swollen joint with fever, which could be a joint infection (septic arthritis), a medical emergency. The risk is higher in RA and on immunosuppressive drugs.
  • Fever, chills, or signs of serious infection while taking methotrexate, biologics, JAK inhibitors, or steroids
  • Chest pain, sudden shortness of breath, or symptoms of stroke. RA raises cardiovascular risk.
  • A new or worsening dry cough or breathlessness, which can signal lung involvement or, rarely, a drug reaction
  • A painful red eye or change in vision
  • New neck pain with numbness, tingling, or weakness in the arms or legs, or trouble walking (rare, but RA can affect the upper cervical spine)
  • Mouth ulcers, unexplained bruising or bleeding, or yellowing of the skin while on DMARDs

See your doctor soon (not urgently) if you have joint swelling that lasts more than a few weeks, morning stiffness that lasts over 30 minutes, or a family history of RA with new joint symptoms. If you already have RA, see your doctor if your disease keeps flaring despite treatment.

Frequently asked questions

What causes rheumatoid arthritis?

RA is an autoimmune disease in which the immune system attacks the joint lining. It arises from an interaction between genetic susceptibility (especially HLA-DRB1 "shared epitope" genes) and environmental exposures. Smoking is the best-established exposure. Researchers also propose that RA autoimmunity may begin at mucosal surfaces such as the gums, lungs, and gut, but those triggers are still being studied.

Why does early treatment matter so much?

Joint damage can begin within months of symptom onset. Starting DMARDs early, ideally within the first few months, is associated with less joint damage, higher remission rates, and better long-term function. Lifestyle measures can support treatment but do not replace it. If you have persistent joint swelling, see a doctor promptly and ask about referral to a rheumatologist.

What do anti-CCP and rheumatoid factor tests mean?

Both are blood tests used in diagnosing RA. Anti-CCP is highly specific for RA and can appear years before symptoms. Rheumatoid factor is less specific and can be positive in other conditions and in some healthy older adults. About a third of people with RA test negative for anti-CCP, and some are negative for both tests (seronegative RA). Results must be interpreted by a physician together with symptoms and examination.

Can diet or supplements cure rheumatoid arthritis?

No diet or supplement has been shown to cure RA. A Mediterranean-style diet, omega-3 fish oil, regular exercise, quitting smoking, and good dental care have evidence of modest benefit or support overall health alongside medical treatment. Never stop or reduce prescribed RA medication without speaking to your rheumatologist.

I tested positive for anti-CCP but have no joint symptoms. What now?

A positive anti-CCP without arthritis raises the risk of developing RA, but not everyone with the antibody goes on to develop it. Discuss monitoring with a rheumatologist. Clinical trials are testing whether early intervention can prevent RA in high-risk people. In the meantime, not smoking, caring for your gums, staying active, and keeping a healthy weight are sensible steps.

Is RA the same as osteoarthritis?

No. Osteoarthritis is a degenerative joint disease that commonly affects weight-bearing joints and worsens with use. RA is an autoimmune, systemic inflammatory disease that typically affects small joints symmetrically, causes prolonged morning stiffness, and requires immune-modulating treatment.

References

  1. Rheumatoid Arthritis — National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH. niams.nih.gov/health-topics/rheumatoid-arthritis
  2. Rheumatoid Arthritis — American College of Rheumatology (patient information). rheumatology.org/patients/rheumatoid-arthritis
  3. Rheumatoid Arthritis (RA) — Centers for Disease Control and Prevention (CDC). cdc.gov/arthritis/rheumatoid-arthritis
  4. Rheumatoid arthritis — World Health Organization fact sheet. who.int/news-room/fact-sheets/detail/rheumatoid-arthritis
  5. Rheumatoid arthritis — MedlinePlus, U.S. National Library of Medicine. medlineplus.gov/rheumatoidarthritis.html
  6. Smolen JS, Edwards CJ, Konzett V, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update. Ann Rheum Dis. 2026. PubMed 41826212 (supersedes the 2022 update, PubMed 36357155)
  7. Fraenkel L, et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res 2021. PubMed 34101387
  8. Klareskog L, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006. PubMed 16385494
  9. Scher JU, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2013. PubMed 24192039
  10. Wegner N, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum 2010. PubMed 20506214
  11. Holers VM, et al. Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. Nat Rev Rheumatol 2018. PubMed 30111803
  12. Nielen MM, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004. PubMed 14872479
  13. Rantapää-Dahlqvist S, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003. PubMed 14558078
  14. Aletaha D, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum / Ann Rheum Dis 2010. PubMed 20872595
  15. Sugiyama D, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2010. PubMed 19174392
  16. Qin B, et al. Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis. Arthritis Res Ther 2015. PubMed 25890172
  17. Hazes JM, et al. Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use. Rheumatology (Oxford) 2011. PubMed 21890617
  18. Toussirot E, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol 2008. PubMed 19028369
  19. Finckh A, et al. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum 2006. PubMed 17139662
  20. Rausch Osthoff AK, et al. 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis 2018. PubMed 29997112 (2025 update: Rausch Osthoff AK, et al. Ann Rheum Dis 2026, PubMed 42036268)
  21. Gwinnutt JM, et al. 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases. Ann Rheum Dis 2023. PubMed 35260387
  22. Agca R, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 2017. PubMed 27697765
  23. Hagen KB, et al. Dietary interventions for rheumatoid arthritis. Cochrane Database of Systematic Reviews 2009. PubMed 19160281
  24. Sköldstam L, et al. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Ann Rheum Dis 2003. PubMed 12594104
  25. Proudman SM, et al. Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Ann Rheum Dis 2015. PubMed 24081439
  26. Hahn J, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ 2022. PubMed 35082139
  27. Kjeldsen-Kragh J, et al. Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet 1991. PubMed 1681264
  28. Gkiouras K, Grammatikopoulou MG, Myrogiannis I, et al. Efficacy of n-3 fatty acid supplementation on rheumatoid arthritis' disease activity indicators: a systematic review and meta-analysis of randomized placebo-controlled trials. Crit Rev Food Sci Nutr. 2024. PubMed 35900212
  29. GBD 2021 Rheumatoid Arthritis Collaborators. Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023. PubMed 37795020
  30. Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012;71(9):1524–1529. PubMed 22425941
  31. Liu X, Tedeschi SK, Barbhaiya M, et al. Impact and timing of smoking cessation on reducing risk of rheumatoid arthritis among women in the Nurses' Health Studies. Arthritis Care Res. 2019;71(7):914–924. PubMed 30790475
  32. Liu Y, Hazlewood GS, Kaplan GG, Eksteen B, Barnabe C. Impact of obesity on remission and disease activity in rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res. 2017;69(2):157–165. PubMed 27159376
  33. Sun J, Zheng Y, Bian X, et al. Non-surgical periodontal treatment improves rheumatoid arthritis disease activity: a meta-analysis. Clin Oral Investig. 2021;25(8):4975–4985. PubMed 33515120
  34. Hartmann AM, Dell'Oro M, Spoo M, et al. To eat or not to eat — an exploratory randomized controlled trial on fasting and plant-based diet in rheumatoid arthritis (NutriFast-Study). Front Nutr. 2022;9:1030380. PubMed 36407522
  35. Costenbader KH, Cook NR, Lee IM, et al. Vitamin D and marine n-3 fatty acids for autoimmune disease prevention: outcomes two years after completion of a double-blind, placebo-controlled trial. Arthritis Rheumatol. 2024;76(6):973–983. PubMed 38272846